About this trial
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Contraindication to regional anesthesia
allergy
refusal of the injection
Trial design
Single group
Treatments tested in this trial
Deep posterior post gluteal nerve block
Procedure/SurgeryOne injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur.
Treatment groups
Trial outcomes
Primary outcomes
Sciatic nerve block
number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet)
Secondary outcomes
Pain postoperative
Visual analogic pain (VAS) AT 6 hours 0 : no pain 10: maximum pain
pain 2
Visual analogic pain (VAS) AT 12 hours 0 : no pain 10: maximum pain
oPIOID Consumption
Opioid consumption per and postoperative until 48 hours
RAAC
QOR15 scale at H24 and H48 questionnaire with 15 questions from 0 to 10 (https://pqip.org.uk/FilesUploaded/Myles%20QoR-15.pdf)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: